Table 1.
Univariate | Multivariate | ||||
---|---|---|---|---|---|
Variable | Hazard Ratio (95% Confidence Interval) | P-value | Hazard Ratio (95% Confidence Interval) | P-value | |
Training Set | Immune Activation Score (log10 transformed) | 0.1430 (0.03683– 0.5555) | 0.00496* | 0.1688 (0.04039–0.7054) | 0.014758* |
Stage at Diagnosis | 2.1227 (1.439– 3.131) | 0.000147* | 2.0310 (1.33617–3.0871) | 0.000911* | |
Age at Diagnosis | 1.006 (0.9661– 1.048) | 0.765 | 1.0363 (0.99081–1.0840) | 0.119459 | |
Received Chemotherapy | 0.4879 (0.1752– 1.359) | 0.17 | 0.4660 (0.14512–1.4965) | 0.199589 | |
Validation Cohort | Immune Activation Score (log10 transformed) | 0.2111 (0.06075–0.7335) | 0.01440* | 0.1939 (0.05451–0.6896) | 0.011280* |
Stage at Diagnosis | 1.628 (1.204–2.201) | 0.00154* | 1.6363 (1.18309–2.2632) | 0.002920* | |
Age at Diagnosis | 1.013 (0.9812–1.045) | 0.43200 | 1.0198(0.96152–1.0605) | 0.696870 | |
Received Chemotherapy | 0.6166 (0.1986–1.915) | 0.40300 | 0.7696 (0.14986–3.9519) | 0.753700 |
significant P-values